These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19763387)

  • 21. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
    Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
    Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
    Jiang L; Liao A; Yan L; Li B; Zhu W; Wen T
    Hepatogastroenterology; 2014 May; 61(131):747-51. PubMed ID: 26176068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
    Sugawara Y; Tamura S; Makuuchi M
    Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatocellular carcinoma: the Kyoto experience.
    Takada Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):527-32. PubMed ID: 19707711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
    Takada Y; Ito T; Ueda M; Sakamoto S; Haga H; Maetani Y; Ogawa K; Ogura Y; Oike F; Egawa H; Uemoto S
    Dig Dis; 2007; 25(4):299-302. PubMed ID: 17960063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma.
    Lee HW; Suh KS
    Curr Opin Organ Transplant; 2016 Apr; 21(2):231-7. PubMed ID: 26918880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.
    Ng KK; Lo CM; Chan SC; Chok KS; Cheung TT; Fan ST
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):548-54. PubMed ID: 19760139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
    Duffy JP; Vardanian A; Benjamin E; Watson M; Farmer DG; Ghobrial RM; Lipshutz G; Yersiz H; Lu DS; Lassman C; Tong MJ; Hiatt JR; Busuttil RW
    Ann Surg; 2007 Sep; 246(3):502-9; discussion 509-11. PubMed ID: 17717454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living Donor Liver Transplantation for Hepatocellular Carcinoma within Milan Criteria in the Present Era.
    Yoshizumi T; Harimoto N; Itoh S; Okabe H; Kimura K; Uchiyama H; Ikegami T; Ikeda T; Maehara Y
    Anticancer Res; 2016 Jan; 36(1):439-45. PubMed ID: 26722079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UCSF criteria by pre-transplant radiologic study can not assure similar post-transplant results of hepatocellular carcinoma within Milan criteria.
    Ju MK; Choi GH; Huh KH; Joo DJ; Kim SJ; Choi J; Kim MS; Kim SI; Kim YS
    Hepatogastroenterology; 2010; 57(101):819-25. PubMed ID: 21033236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria.
    Sotiropoulos GC; Molmenti EP; Omar OS; Bockhorn M; Brokalaki EI; Lang H; Frilling A; Broelsch CE; Malagó M
    Eur J Med Res; 2006 Nov; 11(11):467-70. PubMed ID: 17182358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
    Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
    Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
    Lee KW; Park JW; Joh JW; Kim SJ; Choi SH; Heo JS; Lee HH; Lee DS; Park JH; Yoo BC; Paik SW; Koh KC; Lee JH; Choi MS; Lee SK
    Transplant Proc; 2004 Oct; 36(8):2289-90. PubMed ID: 15561222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
    Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
    Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.